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Tetraspanins are molecular scaffolds that distribute proteins into highly organized
microdomains consisting of adhesion, signaling, and adaptor proteins. Many reports
have identified interactions between tetraspanins and signaling molecules, finding
unique downstream cellular consequences. In this review, we will explore these
interactions as well as the specific cellular responses to signal activation, focusing on
tetraspanin regulation of adhesion-mediated (integrins/FAK), receptor-mediated (EGFR,
TNF-α, c-Met, c-Kit), and intracellular signaling (PKC, PI4K, β-catenin). Additionally,
we will summarize our current understanding for how tetraspanin post-translational
modifications (palmitoylation, N-linked glycosylation, and ubiquitination) can regulate
signal propagation. Many of the studies outlined in this review suggest that tetraspanins
offer a potential therapeutic target to modulate aberrant signal transduction pathways
that directly impact a host of cellular behaviors and disease states.
Keywords: tetraspanins, signal transduction, tetraspanin-enriched microdomains, adhesion-mediated signaling,
receptor-mediated signal transduction
INTRODUCTION
Tetraspanins are membrane-spanning proteins with a conserved structure that function primarily
as membrane protein organizers. Phylogenetic analysis identified 33 tetraspanins in humans, 37
in Drosophila melanogaster (Charrin et al., 2014), and 20 in Caenorhabditis elegans (Huang et al.,
2005), while only 17 were identified inArabidopsis thaliana (Boavida et al., 2013). Tetraspanins have
also been identified in the ameoba,Dictyostelium discoideum, which exists as both a unicellular and
multicellular organism (Albers et al., 2016). While some tetraspanins are expressed ubiquitously in
humans, others are cell or tissue specific (Maecker et al., 1997; de Winde et al., 2015), providing a
means to regulate the signal transduction associated with a breadth of cellular processes.
Members of the tetraspanin family of proteins have four transmembrane domains, which
contribute to the creation of a small (EC1) and large (EC2) extracellular loop (Figure 1).
The large extracellular loop contains a conserved Cys-Cys-Gly amino acid motif (CCG-
motif), as well as two other conserved cysteine residues. EC2 of CD81 was resolved using
crystallography (Kitadokoro et al., 2001), where the authors demonstrated that the four
conserved cysteine resides within EC2 promote the formation of disulfide bridges, as had
been suggested by previous reports (Levy et al., 1991; Tomlinson et al., 1993; Maecker et al.,
1997). Moreover, molecular modeling studies using the CD81 EC2 structure as a template
predicted the topography of several other tetraspanins including CD37, CD53, CD82, and
CD151 (Seigneuret et al., 2001; Seigneuret, 2006). These studies demonstrated that the EC2
domain of tetraspanins consist of one conserved and one variable domain, with the conserved
domain consisting of a three-helix bundle while the variable domain is unique to particular
tetraspanins. A recent report resolved a crystal structure of full-length CD81, finding that
the four transmembrane domains create a cholesterol-binding pocket (Zimmerman et al., 2016).
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FIGURE 1 | Schematic of tetraspanin molecular structure (Based on
Zimmerman et al., 2016). Cartoon depicting the structural characteristics of
tetraspanins. Tetraspanins have four transmembrane domains (TM1-TM4),
which create one small (EC1) and one large (EC2) extracellular loop as well as
a short inner loop. The N- and C-termini of tetraspanins are localized to the
intracellular side of the membrane. The Cys-Cys-Gly amino acid motif is
depicted in addition to the two characteristic disulfide bonds that are formed in
EC2.
Furthermore, the authors performed molecular dynamics
simulations that suggest CD81 can adopt an open or closed
conformation depending on whether or not cholesterol is bound.
In addition to the defining features of tetraspanins, many
members of the tetraspanin family also contain post-translational
modifications. For example, tetraspanins may be palmitoylated at
membrane proximal cysteine residues, which was demonstrated
to regulate protein-protein interactions (Berditchevski et al.,
2002; Charrin et al., 2002; Yang et al., 2002, 2004). Meanwhile,
tetraspanins can also be N-linked glycosylated at asparagine
residues, which is less clearly understood (Ono et al., 1999;
Stuck et al., 2012; Marjon et al., 2016). Tetraspanins may
also be ubiquitinated at cytoplasmic sites, which contributes to
their down-regulation (Lineberry et al., 2008; Wang Y. et al.,
2012). An example structure of tetraspanin CD82 is depicted in
Figure 2, with the post-translational modifications highlighted.
How these tetraspanin post-translational modifications impact
signal transduction will be addressed in more detail later in this
review.
Through their function as molecular scaffolds, tetraspanins
contribute to organismal development, reproduction, and
immunity (Kaji et al., 2000, 2002; Le Naour et al., 2000; Miyado
et al., 2000; García-Frigola et al., 2001; Levy and Shoham, 2005;
Jarikji et al., 2009; van Spriel, 2011; Han et al., 2012). Consistent
with their expression being primarily found in multicellular
organisms, it is not surprising that many processes to which
tetraspanins contribute center around cell-cell- interactions.
Additionally, numerous tetraspanins are also associated with
the development and progression of disease, in particular, with
respect to cancer and cancer cell-niche interactions (Zoller,
2009; Hemler, 2013). Although tetraspanins do not have known
adhesive ligands or catalytic activity, they contribute to cellular
physiology by organizingmolecules within the plasmamembrane
into microdomains.
The proposed function of tetraspanins is to organize the
plasma membrane by facilitating the formation of what are
FIGURE 2 | CD82 structure and motifs. Cartoon depicting CD82 topology
within the plasma membrane and important motifs. CD82 contains five
membrane proximal cysteine residues (shown in green) at residues 5, 74, 83,
251, and 253, which can be palmitoylated. There are three asparagine
residues in EC2 (shown in orange) that are predicted to be N-linked
glycosylated at residues 129, 157, 198. There are four cytoplasmic lysine
residues 7, 10, 263, and 266 (shown in gray), which are predicted to be
ubiquitinated. The C-terminal tyrosine based sort motif (YXXø) is depicted in
blue at amino acids 261–264; for CD82 this motif is Tyr-Ser-Lys-Val.
termed tetraspanin enriched microdomains (TEMs). TEMs
consist of homophilic and heterophilic interactions amongst
tetraspanins, interactions between tetraspanins and other
membrane proteins, as well as interactions between tetraspanins
and proteins at the membrane/cytoplasm interface (Hemler,
2005; Charrin et al., 2009, 2014; Stipp, 2010). Moreover,
these protein associations can occur through direct binding
between tetraspanins and other proteins or through tetraspanin
interactions with a common binding partner.
Interactions between tetraspanin and signaling molecules
have been detected for various types of proteins, including
adhesion and signaling receptors, and cytosolic signaling
molecules, which are depicted in Figure 3. The downstream
cellular consequences of these interactions vary, ranging
from regulation of cellular adhesion, migration, contractility
and morphology. As recent comprehensive reviews focused
on tetraspanin regulation of immune signaling are available
(Levy and Shoham, 2005; Halova and Draber, 2016), we will
discuss other major classes of signaling molecules regulated
by tetraspanins, as well as the cellular consequences of such
regulations.
TETRASPANINS AND
ADHESION-MEDIATED SIGNALING
One of the most prominent classes of adhesion receptors which
tetraspanins are known to regulate is the integrin family of
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FIGURE 3 | Tetraspanin enriched microdomains with signaling molecules. Illustration of the plasma membrane depicting tetraspanin interactions with
membrane and cytosolic signaling molecules. The downstream signaling consequences attributed to tetraspanin regulation are indicated beneath. Key signaling
molecules modulated by tetraspanins include: (A) Adhesion-Mediated Signaling (Integrins/FAK), (B) Receptor-Mediated Signaling (GPCRs, EGFR, c-kit, c-Met,
ADAMs, TGF), and (C) Intracellular signaling (PKC, PI4K, Rho-GTPases, and β-catenin).
proteins. Integrins are heterodimeric proteins consisting of one α
and one β subunit, and this combination of subunits dictates their
ligand specificity (Humphries et al., 2006). Numerous studies
identified direct and indirect interactions between integrins
and tetraspanins (Slupsky et al., 1989; Rubinstein et al., 1994;
Berditchevski et al., 1996; Mannion et al., 1996; Yáñez-Mo
et al., 2001, 1998; Stipp and Hemler, 2000; Berditchevski, 2001).
Though integrins lack intrinsic catalytic activity, they propagate
signals through a variety of cytoplasmic signaling molecules,
many of which are components of focal adhesions (Schwartz,
2001). Through a combination of imaging and biochemical
studies, researchers showed that tetraspanins colocalize with the
focal adhesion proteins vinculin and talin as well as myrstoylated
alanine-rich C-kinase substrate (MARCKS), which is involved
in PKC-mediated signaling (Berditchevski and Odintsova, 1999).
Moreover, signaling downstream of integrins is also mediated
by the focal adhesion kinase, which is further regulated by
tetraspanins as indicated below.
Focal Adhesion Kinase
Focal adhesion kinase (FAK) is a cytosolic protein which can
interact directly with the integrin cytoplasmic tail, thereby
allowing integrins to link to the actin cytoskeleton and
promote downstream signaling (Schlaepfer et al., 1999).
Immunoprecipitation studies demonstrated that tetraspanins
CD9, CD63, CD81, CD82, and CD151 interact with the
phosphorylated form of FAK (Berditchevski and Odintsova,
1999). Additionally, cells plated on anti-tetraspanin monoclonal
antibodies demonstrated reduced FAK phosphorylation, further
suggesting that tetraspanin scaffolding can contribute to FAK
activation.
As suggested, a number of tetraspanins have been implicated
in FAK regulation. It was shown that the siRNA knockdown
of CD151 resulted in diminished phosphorylation of FAK,
p130Cas, paxillin, and Src (Yamada et al., 2008). In fact,
treatment with a CD151 monoclonal antibody, which reduced
CD151 interactions with α3β1, also led to a reduction in FAK
phosphorylation. In an attempt to rescue this phenotype, control
or CD151 knockdown cells were treated with a β1 integrin
activating antibody and these data demonstrated that FAK
phosphorylation could not be rescued under enforced integrin
activation. As such, this study provides evidence that tetraspanins
may regulate integrin-mediated signaling through a mechanism
independent of initial integrin activation. The authors quantified
FAK autophosphorylation (Tyr397), which is a FAKmodification
stimulated by integrin clustering (Schlaepfer et al., 1999). As
tetraspanins have been previously demonstrated to regulate
integrin clustering (van Spriel et al., 2012; Termini et al., 2014),
perhaps the loss of CD151 diminishes integrin clustering, thereby
reducing FAK phosphorylation. Additionally, the presence of
CD151 increased FAK and Src phosphorylation in response to
plating on extracellular matrix components, which modulated
GTPase activation and downstream cell migration (Hong et al.,
2012). The authors demonstrated that there is a greater increase
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in FAK and Src activation in response to plating on laminin
than fibronectin, which is consistent with previous findings
that CD151 is closely associated with laminin binding integrins
(Berditchevski et al., 2002; Stipp, 2010).
Another tetraspanin identified to regulate FAK activity
is CD9. In the case of lymphatic dermal endothelial cells,
CD9 knockdown diminished FAK phosphorylation in response
to VEGF-1 administration, demonstrating that tetraspanin
regulation of FAK signaling can occur through multiple
activating stimuli (Iwasaki et al., 2013). The authors further
demonstrated that this CD9-mediated reduction in post-
adhesion signaling impaired lymphangiogenesis. Consistent with
previous studies of CD151 (Yamada et al., 2008), Rocha-
Perugini et al. demonstrated that silencing of CD151 or CD9
reduced the expression of phospho-FAK and phospho-ERK in
response to T-cell engagement (Rocha-Perugini et al., 2014).
A decrease in the accumulation of activated β1 integrins and
phospho-FAK was also detected at the immune synapse in
CD9 and CD151 knockdown cells, suggesting that CD9 and
CD151 promote the recruitment to and retention of integrins
at the immune synapse, which results in diminished integrin
downstream signaling. Therefore, the influence that tetraspanins
have on integrin localization provides a critical means to regulate
integrin-mediated signaling.
Though not technically considered a tetraspanin, the L6
tetraspan protein, TM4SF5, has sequence characteristics and
structural properties similar to tetraspanins (Wright et al., 2000).
It was shown that the intracellular loop of tetraspan TM4SF5
is critical for promoting an interaction between TM4SF5 and
FAK (Jung et al., 2012). The authors performed in vitro pull-
down assays using the N- or C-terminal cytoplasmic regions of
TM4SF5 or the TM4SF5 intracellular loop to assess FAK binding.
It was found that only the intracellular loop interacted with
FAK, although the precise sites of association remain unknown.
Future studies focused on identifying the particular amino acid
residues within tetraspans that promote this association may
offer potential targets to attenuate FAK signaling, which can be
deregulated in numerous types of cancer (Sulzmaier et al., 2014).
TETRASPANINS AND
RECEPTOR-MEDIATED SIGNALING
G-Protein Coupled Receptors
G-protein coupled receptors (GPCRs) are seven membrane-
spanning proteins that transmit signals with the help of
intracellular G proteins (Kobilka, 2007). Upon ligand binding,
GPCRs can be coupled to Gα, Gβ, and Gγ subunits to activate
numerous cellular responses including calcium and potassium
channel regulation, as well as phospholipase C (PLC) and
phosphoinositide 3-kinase (PI3K) signaling (Tuteja, 2009). With
the use of model systems such as Drosophila, it was determined
that tetraspanins can regulate GPCR-mediated signaling. For
example, the Drosophila-specific tetraspanin, Sunglasses or Sun,
is required for the light-induced down-regulation of rhodopsin,
a light-sensitive GPCR (Xu et al., 2004). Interestingly, Sun was
concentrated in the retina and removal of Sun resulted in retinal
degeneration. Moreover, the authors determined that in flies with
reduced Sun expression, extended exposure to light resulted in
the diminished ability to down regulate rhodopsin. In line with
these findings, Sun is most closely related to human tetraspanin,
CD63, which is enriched within the lysosome (Metzelaar et al.,
1991). Therefore, it is likely that Sun assists with GPCR signal
attenuation by directing its endosomal trafficking in a similar
manner to CD63. Additionally, an interaction between Sun and
the Gq subunit of rhodopsin was identified, which was further
proposed to help Sun promote the endocytosis of rhodopsin (Han
et al., 2007).
The regulation of GPCRs by human tetraspanins has also been
explored. It was shown that the GPCR, GPR56, associates with
tetraspanins CD9 and CD81 (Little et al., 2004; Xu and Hynes,
2007), two tetraspanins which have also been demonstrated to
interact with one another (Stipp et al., 2001). Through the use
of mass spectrometry, it was also determined that the G protein
subunits, Gα11 Gαq and Gβ associate with CD81 and further
immunoprecipitation studies demonstrated that this association
is not detected with tetraspanins CD63 or CD151 (Little et al.,
2004). The authors postulate that perhaps the regulatory role of
tetraspanins with respect to GPCRs may be to enhance ligand
binding and downstream signaling, though this has yet to be
directly tested. Important future studies will involve the analysis
of downstream signaling through tetraspanin-mediated changes
in GPCRs, including the potential regulation of GPCR-ligand
affinity.
Epidermal Growth Factor Receptor
In addition to GPCRs (Metzelaar et al., 1991; Xu et al., 2004;
Han et al., 2007) and integrins (He et al., 2005; Winterwood
et al., 2006; Termini et al., 2014), tetraspanins have also
been demonstrated to regulate the trafficking and signaling
downstream of the epidermal growth factor receptor (EGFR).
EGFR is a transmembrane receptor that can be activated by
numerous ligands including epidermal growth factor (EGF) and
transforming growth factor-α (TGF-α). Ligand binding induces
EGFR dimerization, which enhances EGFR catalytic activity (Jura
et al., 2009; Valley et al., 2015). Moreover, EGFR endocytosis
can serve as both a positive and negative regulatory signaling
mechanism (Tomas et al., 2014). The contribution of tetraspanins
in mediating EGFR trafficking has been extensively studied
(Odintsova et al., 2000, 2003; Berditchevski and Odintsova,
2007).
Through a series of immunoprecipitation studies, it was
shown that tetraspanin CD82 associates with EGFR and the
overexpression of CD82 controls the phosphorylation kinetics of
EGFR, Grb2, and Shc (Odintsova et al., 2000). It was determined
that this regulation mediates the morphological response of
HB2 cells to EGF stimulation. Interestingly, in cells expressing
CD82, there was a more rapid down-regulation of EGFR upon
EGF stimulation compared to cells that do not express CD82,
indicating that CD82 contributes to EGFR down-regulation
through modified internalization kinetics. This led the authors
to suggest that the presence of CD82 modulates the signaling
potency of the receptor even before it is activated. Furthermore,
the authors speculate that the combination of reduced CD82 and
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increased EGFR expression may lead to uncontrolled signaling.
Therefore, CD82, and likely other tetraspanins, may provide
a means to attenuate signaling through modulations in EGFR
trafficking. A follow-up study found that CD82 negatively
regulates ligand-induced dimerization of EGFR, but does not
affect the dimerization of ErbB2 or ErbB3 (Odintsova et al.,
2003). Although the authors did not examine the downstream
effects of altered dimerization, they suggest that the differential
compartmentalization of EGFR by CD82 might alter cellular
signaling.
Further studies examined the role of the vesicular associated
membrane protein (VAMP), TI-VAMP, and CD82 in regulating
the surface dynamics of EGFR. In this study, knockdown
of CD82 led to increased EGFR endocytosis upon EGF
stimulation through increased AP-2 recruitment (Danglot et al.,
2010). Furthermore, CD82 knockdown also altered the EGFR
diffusion patterns on the plasma membrane and reduced ERK
phosphorylation upon EGF stimulation, providing evidence that
tetraspanins can regulate the spatial dynamics of proteins for
controlling downstream signaling. This report provides a unique
mechanism by which CD82, through cooperation with TI-VAMP
and AP-2, can regulate EGFR signaling and surface dynamics.
Moreover, the authors propose that these regulatory mechanisms
may be in part controlled by CD82-mediated alterations in actin
dynamics or the membrane lipid composition.
EGFR regulation by CD82 was also shown to mediate
ganglioside production. More specifically, the overexpression of
CD82 in combination with inhibition of ganglioside production
resulted in increased EGFR phosphorylation in response to
EGF stimulation (Li Y. et al., 2013). The authors speculate
that significant interplay occurs between glycosphingolipid
enriched microdomains and TEMs, which cooperatively regulate
cellular signaling. The overexpression of CD82 might promote
EGFR clustering, which may stimulate dimerization and
thereby enhance downstream EGFR signaling. Alternatively,
the reduction in ganglioside production might improve EGFR
phosphorylation by reorganizing the receptors into clusters
within TEMs, since gangliosides have been demonstrated to
contribute to TEM organization (Odintsova et al., 2006).
Beyond the prominent role of CD82 in regulating EGFR,
additional studies also identified CD9 as a mediator of EGFR
signaling. With the use of an autocrine system of MDCK cells co-
expressing CD9 and TGF-α, TGF-α stimulation promoted EGFR
activation (Shi et al., 2000). The authors also utilized a paracrine
system whereby CHO cells expressing TGF-α alone or TGF-α
and CD9 together were plated with 32D cells expressing EGFR.
This experiment demonstrated that co-expression of TGF-α and
CD9 increases EGFR activation, although the precise mechanism
by which CD9 modulates EGFR signaling remains unclear.
Regardless, this study provides unique insight into how CD9
may regulate cellular signaling initiated through contact between
adjacent cells. Interestingly, another report investigated the effect
of CD9 expression on EGFR signaling, finding that increased
expression of CD9 resulted in decreased phosphorylation of
EGFR, Shc, and total Grb2 expression (Murayama et al., 2008).
Though these studies demonstrate opposing effects of CD9
on EGFR, they also indicate that TNF-α plays a role in
mediating EGFR activation through CD9. These studies open the
possibility that other tetraspanins such as CD82 may also work
in concert with TNF-α, similar to CD9 and TNF-α in mediating
EGFR activation. Therefore, future analyses would benefit from
examining the interplay of TNF-α with other tetraspanins in
regulating EGFR signaling.
c-Kit
The stem cell factor receptor or c-Kit (CD117) is a receptor
tyrosine kinase that binds to its ligand, stem cell factor
(SCF), which is also known as steel factor (SLF) or kit
ligand (Lennartsson and Rönnstrand, 2012). c-Kit signaling can
activate several signaling cascades, including PI3K, Src family
kinases, and MAPK to name a few. Moreover, c-Kit mediated
signaling can control numerous cellular processes including
migration, survival and the differentiation of hematopoietic
progenitor cells. With the use of immunoprecipitation studies,
it was determined that c-Kit associates with tetraspanins
CD9, CD63, and CD81 and this interaction was enhanced
upon treatment with SCF (Anzai et al., 2002). Although the
authors found increased phosphorylation of c-Kit within the
immunoprecipitated fraction, they determined that this does not
enhance kinase activity in response to SCF treatment. Rather,
the kinetics of SCF binding to c-Kit were altered when c-Kit
associated with CD63. The authors suggest that this might be
because free c-Kit is internalized upon SCF binding, implying
that perhaps the CD63/c-Kit complex is more stable on the
cellular surface. While this study alludes to a role for tetraspanins
in regulating c-Kit phosphorylation, further analysis is necessary
to determine the downstream consequences of tetraspanin
mediated c-Kit activation. Additionally, the possibility that
tetraspanins, such as CD63, might stabilize c-Kit and modulate
signaling through alterations in protein trafficking could have
significant impact on specific leukemias where c-Kit expression
and activation are known to be dysregulated (Ikeda et al., 1991;
Goemans et al., 2005; Boissel et al., 2006; Corbacioglu et al., 2006;
Paschka et al., 2006).
c-Met
c-Met is a receptor tyrosine kinase that can activate numerous
pathways to promote cellular survival, motility, and proliferation
(Birchmeier et al., 2003). Hepatocyte growth factor (HGF)
binding to c-Met causes c-Met dimerization, which helps
to initiate various cellular signaling cascades including AKT,
ERK/MAPK, and JNK (Organ and Tsao, 2011). Furthermore,
the overexpression of CD82 diminished the phosphorylation of
c-Met in response to integrin ligand engagement, resulting in
reduced Src phosphorylation (Sridhar and Miranti, 2006). In the
case of invasive tumor situations, the authors’ data suggest that
the loss of CD82 leads to enhanced activation of c-Met through
integrin activation. Although the regulatory mechanism remains
unknown, this study provides a clear indication that tetraspanins
can modulate c-Met mediated signaling downstream of integrin
engagement.
It was also shown through immunoprecipitation studies that
CD82 and c-Met interact (Takahashi et al., 2007). Moreover,
the authors demonstrated that upon the ectopic expression of
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CD82, activation of c-Met with HGF led to increased formation
of lamellipodia and filipodia through modulations in GTPase
activities. Additionally, the ectopic expression of CD82 also
prevented c-Met association with Grb2 and PI3K, implicating
that CD82 has an inhibitory role with respect to these binding
events. As such, perhaps the Grb2 and PI3K binding sites within
c-Met become inaccessible in the presence of the c-Met/CD82
interaction.
The regulatory role of CD82 with respect to c-Met-mediated
signaling has also been extended to controlling ERK1/2 and
AKT signaling in hepatocellular carcinoma cells (Li Y. et al.,
2013). An alternative report focused on CD151 with respect
to Met signaling, showing that knockdown of CD151 led to
diminished HGF-induced proliferation (Franco et al., 2010).
The researchers determined that CD151 knockdown decreased
tyrosine phosphorylation of the β4 integrin subunit, which
decreased MAPK signaling through ERK in response to HGF.
Therefore, this study suggests that the c-Met-CD151-β4 complex
is critical for MAPK signaling. While the molecular link between
tetraspanins and ERK or AKT downstream of c-Met remains
an open question, this work implicates integrins as a possible
connection.
Transforming Growth Factor Signaling
Transforming growth factor α (TGF-α) is synthesized as
a transmembrane protein, which can become cleaved by
metalloproteinases to release soluble TGF-α (Pandiella and
Massagué, 1991). This cleavage is stimulated by endotoxins
(Breshears et al., 2012; Liu Z. et al., 2013) and ROS (Boots
et al., 2009) and is mediated primarily by ADAM17 (Peschon
et al., 1998), but also by ADAM10 (Hinkle et al., 2003) and
MeprinA (Bergin et al., 2008; Minder et al., 2012; Singh and
Coffey, 2014). Moreover, TGF-α can interact with and activate
EGFR on neighboring cells (Schlessinger and Ullrich, 1992;
Thorne and Plowman, 1994; Moral et al., 2001). An association
between CD9 and transmembrane TGF-α was identified and
found to be dependent on the TGF-α ectodomain (Shi et al.,
2000). The experimenters illustrated that the cleavage of TGF-
α was inhibited by CD9, implicating a role for the association
between CD9 and TGF-α as a means of protecting TGF-α from
proteolytic cleavage. The authors suggested that the inhibition
of TGF-α cleavage feeds into enhanced TGF-α induced EGFR
activation, which can increase cellular proliferation. This study
provides evidence that tetraspanins, such as CD9, can promote
cellular signaling by stabilizing transmembrane proteins, thereby
providing a potent activation stimulus to mediate juxtacrine
signaling. Protein kinase C (PKC) and MAPK signaling can also
regulate TGF-α cleavage (Baselga et al., 1996; Fan and Derynck,
1999). As tetraspanins can regulate PKC and MAPK signaling
(Zhang et al., 2001; Termini et al., 2016), a closer examination
into the interplay between these molecules in mediating TGF-
α signaling may provide a more comprehensive view of the
complex regulatory networks at play within TEMs.
A follow up study demonstrated that CD9 expression
enhances TGF-α expression at the cell surface using MDCK
cells (Imhof et al., 2008). Here, CD9 was shown to promote
the trafficking of TGF-α from the Golgi to the cell surface
by stabilizing the glycosylated and prodomain-removed forms
of TGF-α. Furthermore, the authors demonstrated that the
expression of TGF-α and CD9 alters actin organization
and focal adhesion formation, supporting the notion that
the combination of CD9 and TGF-α expression produces
dramatically different signaling responses than the expression
of TGF-α alone. Therefore, the tetraspanin expression profile
should be considered when characterizing TGF-α signaling,
particularly in many cancers where TGF-α expression is thought
to support cancer progression (Kenny and Bissell, 2007).
Additionally, the contribution of tetraspanins to the
regulation of the TGF isoform TGF-β1 has been assessed.
Researchers used CD151 knockdown MDA-MB-231 cells
and determined that in the presence of TGF-β1, CD151
knockdown cells had a significantly decreased proliferative rate
compared to control cells (Sadej et al., 2010). More specifically,
in the CD151 knockdown cells, TGF-β1 stimulation led to
reduced p38 phosphorylation, resulting in decreased metastasis.
Mechanistically, the authors propose that CD151 modulations
of the plasma membrane may alter the distribution of TGF-β1
receptors and downstream signaling. Future studies may focus on
determining how CD151 modulates the molecular organization
of the TGF receptor, as this may provide a mechanism to regulate
downstream signaling.
A Disintegrin and Metalloproteases
The A Disintegrin and Metalloprotease (ADAM) family
of transmembrane and secreted proteins contribute to the
regulation of cellular adhesion, migration, proliferation, and
signaling (Seals and Courtneidge, 2003). As the name states,
ADAMs contain a disintegrin and a metalloprotease domain.
While the metalloprotease domain can cleave extracellular
matrix (ECM) components and mediate ectodomain shedding
of cytokines, growth factors, the disintegrin domain can interact
with integrins. Recent comprehensive reviews provide insight
on the role that tetraspanins play in regulating membrane
proteases, with a particular emphasis on their role in regulating
ADAM10 and ADAM17 (Yáñez-Mo et al., 2011; Matthews
et al., 2016). Initial reports demonstrated that ADAM10 is
associated with CD9, CD81, and CD82, indicating that ADAM10
likely exists within TEMs. Interestingly, treatment with anti-
tetraspanin antibodies stimulated the release of TNF-α and
EGF in an ADAM10-mediated manner. Furthermore, through
mass spectrometry studies and extensive immunoprecipitation
studies, Tspan12 was found to associate with ADAM10, which
contributed to the ability of ADAM10 to process amyloid
precursor protein for shedding (Xu et al., 2009). Using several
mutated TSPAN12 constructs, this association was determined
to be regulated by EC1, the C-terminal tail and TSPAN12
palmitoylation. More recent co-immunoprecipitation studies
revealed that the subgroup of TspanC8 tetraspanins (Tspan5,
10, 14, 15, 17, and 33) interact with ADAM10 (Dornier et al.,
2012). Additionally, ADAM17 was also found to associate with
tetraspanin CD9 in leukocytes and endothelial cells, which
diminishes ADAM17-mediated TNF-α and ICAM-1 shedding.
Interestingly, CD9 can regulate the catalytic activity of ADAM17
with regards to shedding of LR11 in monocytes, promonocytes
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and B-lymphoblastoid cell lines (Tsukamoto et al., 2014). As
ADAMs are implicated in regulating various cancer cell types
(Mochizuki and Okada, 2007), the role of tetraspanins in
regulating ADAMs in malignant cells will provide significant
insight and perhaps a means to attenuate aberrant ADAM
activity.
ADAMs are produced as immature, inactive, preforms in
the endoplasmic reticulum. During trafficking from the ER to
the plasma membrane, the enzyme’s prodomain is removed
and ADAMs are then rendered catalytically active (Seals
and Courtneidge, 2003). Interestingly, it was determined that
TspanC8 contributes to ADAM10 maturation and ultimately
the stabilization of ADAM10 at the cell surface (Prox
et al., 2012). Furthermore, Tspan33 knockdown in erythrocytes
resulted in diminished ADAM10 surface expression. Meanwhile,
ADAM10 surface expression remained unchanged in platelets,
demonstrating that tetraspanin regulation of ADAM10 is likely
cell-type specific (Haining et al., 2012). Additionally, the role of
Tspan33 in regulating ADAM10 for the control of macrophage
activation was recently explored (Ruiz-García et al., 2016).
Researchers utilized Tspan33 overexpressing Raw 264.7 cells
and demonstrated that increased Tspan33 expression results
in increased ADAM10 processing, consistent with the earlier
aforementioned studies.
TETRASPANINS AND INTRACELLULAR
SIGNALING
Although tetraspanins are known to primarily affect the
properties of other membrane proteins, they have also been
shown to regulate cytoplasmic signaling molecules. Signaling
proteins are often recruited to the cytoplasmic interface of the
plasma membrane where they initiate signaling and TEMs can
serve as a potential membrane recruitment site. Therefore, in
the following section, we will review how tetraspanins control
the localization, kinetics, and signaling properties of cytosolic
proteins.
Protein Kinase C
The protein kinase C (PKC) family of intracellular signaling
proteins consists of isoforms, which are further classified
into conventional, novel or atypical isoforms (Newton, 1995).
PKCs can phosphorylate several targets, including the myosin
light chain II (Liu X. et al., 2013), PKD2 (Waldron et al.,
2001; Navarro and Cantrell, 2014), Ras GEFs (Jun et al.,
2013), and the β1 integrin tail (Stawowy et al., 2005), which
collectively contribute to the regulation of cell proliferation,
apoptosis, and adhesion amongst other cellular behaviors (Kang,
2014). The interaction between tetraspanins and PKC was
originally demonstrated in K562 cells using an elaborate series
of immunoprecipitation experiments (Zhang et al., 2001). The
experimenters used phorbol 12-myristate 13-acetate (PMA),
which mimics diacylglycerol (DAG) to activate PKC (Castagna
et al., 1982). Under PMA stimulated conditions tetraspanins
CD9, CD53, CD81, and CD82 individually interact with PKCα
and not with PI3K. Additionally, they determined that CD81
and CD151 associate with PKCβII. Moreover, in a PKCα pull-
down, β1, α3, and α6 integrins were detected in complex with
PKC. Therefore, it was suggested that tetraspanins serve to link
PKC to integrins. In order to assess the tetraspanin domains
that control PKC associations, chimeric mapping was performed
by replacing portions of CD9 with portions of the non-PKC
associating tetraspanin, A15/Talla1. These findings demonstrated
that PKC association with tetraspanins occurs outside of the short
inner loop, the large outer loop, and transmembrane 3 or 4.
A recent report also demonstrated that tetraspanin CD151
regulates skin squamous cell carcinoma through STAT3 and
PKCα signaling (Li Q. et al., 2013). Utilizing wild type or CD151
ablated A431 epidermoid carcinoma cells, it was shown that
the loss of CD151 reduces STAT3 activation in response to 12-
O-Tetradecanoylphorbol-13-acetate (TPA) stimulation, which is
another known activator of PKCα. The authors found that PKCα
only associates with α6β4 upon TPA stimulation when CD151
is present. Together, these data suggest that perhaps the role
for CD151 is to recruit PKCα into close proximity with the
α6β4 integrin, which ultimately aids in the phosphorylation of
α6β4. As such, these data build upon previous implications that
tetraspanins link PKC to integrins (Zhang et al., 2001), but also
provide evidence that this scaffolding is important for epidermal
proliferation and STAT3 activation.
Another interesting report investigated how CD9, CD81,
and CD151 expression affects PKCα association with TEMs
(Gustafson-Wagner and Stipp, 2013). It was demonstrated
that CD9/CD81 knockdown diminishes the ability for the α3
integrin to associate with PKCα, which delays cell spreading on
laminin and directed migration. In contrast, CD151 knockdown
enhanced the association of PKCα with the α3 integrin, while
promoting cell migration on collagen-I. The authors propose
that CD9/81 may serve as linkers of PKC to the α3 integrin
subunit, or there might be an indirectly associating molecule
at play. Furthermore, the authors propose that perhaps upon
CD151 depletion, there is increased association between PKC
and α3 due to the loss of CD151, which makes CD9/81 available
to fully associate with α3, thereby promoting PKC-integrin
association. This study provides substantial evidence that the
roles of tetraspanins CD9, CD81, and CD151 are unique in their
regulation of PKCα-integrin interactions.
Further examination into the regulatory role of tetraspanins
with respect to PKC-mediated signaling has uncovered many
unique cellular responses. For example, treatment of A431 cells
with Calphostin C to inhibit PKCα reduced filipodia extensions
as well as E-cadherin puncta formation, demonstrating the
involvement of actin in tetraspanin-regulated PKC signaling
(Shigeta et al., 2003). The authors suggest that CD151 directly or
indirectly associates with PKCα, which they propose may activate
Cdc42 to promote filipodia formation.
A more recent report from our laboratory demonstrated
that CD82 regulates PKCα signaling in acute myeloid leukemia
(AML) (Termini et al., 2016). Using quantitative FRET imaging
and KG1a AML cell lines that overexpress wild type CD82 or a
palmitoylation deficient form of CD82 (Delandre et al., 2009),
we found that upon PMA stimulation, PKCα was recruited to
the plasma membrane where it associates with CD82. However,
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upon extended PMA stimulation, this PKCα/CD82 association
is reduced in cells overexpressing the palmitoylation deficient
form of CD82, demonstrating that the palmitoylation of CD82
regulates the stability of the PKCα interaction. We went on to
use super-resolution imaging to examine how the scaffolding
properties of CD82 regulate the macromolecular clustering of
PKCα and found that upon disruption of the CD82 scaffold,
there is a significant reduction in the size of PKCα clusters.
Moreover, using CD82 knock-down cells, we found that while
PKCα is still recruited to the membrane upon PMA stimulation,
large-scale PKCα clusters are not detected. This change in
PKCα clustering was then linked to alterations in downstream
ERK1/2 signaling that influenced the aggressive phenotype of
AML (Termini et al., 2016). Interestingly, the kinetics of PKCα
oligomerization were recently quantified and modeled using
HEK cells where they found that the intramolecular clustering of
PKCα contributes to downstream phosphorylation (Bonny et al.,
2016). Collectively, these studies illustrate that the modulation of
signaling molecule clusters may serve as an important regulatory
mechanism for stabilizing and/or attenuating signal transduction
pathways. Moreover, our work implicates tetraspanins as critical
mediators of cluster size and stability. Future super resolution
imaging studies focused on identifying how the clustering of
tetraspanins can modulate downstream signaling through PKC
and other molecules such as Rac or Cdc42 would be valuable to
help clarify how tetraspanins and PKCα mediate cytoskeleton-
dependent cellular responses such as adhesion and migration.
An interesting link was also discovered between PKC and
EGFR-mediated signaling that is enhanced by CD82. c-Cbl is an
ubiquitin ligase recruited to EGFR where it assists with receptor
down-regulation (Joazeiro et al., 1999). The authors found that
PKC mediates c-Cbl phosphorylation upon EGF stimulation
in CD82 expressing H2B cells (Odintsova et al., 2013). The
phosphorylation of c-Cbl serves as a negative regulator of
enzyme function (Ryan et al., 2006), which may be responsible
for inhibiting EGFR downregulation. Therefore, without CD82
present, EGFR can be quickly downregulated as PKC is not
present to regulate c-Cbl. Collectively, these studies provide
substantial evidence that implicates tetraspanins as signaling
scaffolds that promote the close proximity of PKC with integrins,
EGFR and cytoplasmic proteins like c-Cbl.
Phosphatidylinositol 4-Kinase
Phosphatidylinositol 4-kinase (PI4K) catalyzes the conversion
of phosphatidylinositol (PI) to phosphatidylinositol 4-phosphate
(PI4P), which is an important intermediate for lipid-mediated
signaling (Clayton et al., 2013). A series of biochemical
experiments demonstrated that PI4K exists within α3 integrin
and CD63 containing TEMs (Berditchevski et al., 1997).
The authors suggest that perhaps TEMs are responsible for
linking the α3β1 integrin to PI4K. A follow up study from
the same group explored this further, demonstrating that
immunoprecipitation of α3 or CD151 yields similar levels
of PI4K activity based upon PI4P production (Yauch et al.,
1997). Additionally, using cells with diminished α3 expression,
CD151 was pulled down, demonstrating that there is still
PI4K associated with the complex. Conversely, immunodepletion
of CD151 resulted in significantly diminished lipid kinase
activity associated with α3, while CD63 and/or CD81 deletion
did not have as significant of an effect. Collectively, these
data implicate CD151 as a critical linker between PI4K
and α3β1, which the authors suggest may support cell
migration.
A subsequent follow up study demonstrated that PI4K
associates with tetraspanins A15/TALLA1, CD63, CD151,
CD9, and CD81, however it does not appear to associate
with NAG-2, CD53, CD37, or CD82 (Yauch and Hemler,
2000). Moreover, PI3K and PI4P5K activity were not detected
in CD63, CD81, and CD151 complexes, indicating that
perhaps the association is specific to PI4K. Studies with
CD9/CD82 chimeras were unsuccessful at determining
the site of association with PI4K. Therefore, a closer
examination into the structural domains within tetraspanins
that contribute to their association with PI4K could provide
insight into the mechanism by which tetraspanins may
regulate the catalytic activity of PI4K and downstream
responses.
GTPases
RhoGTPases mediate signal transduction by switching between a
GTP-bound (active) and GDP-bound (inactive) state (Bishop and
Hall, 2000). There are numerous effector proteins downstream of
GTPases including PI3K, PI-4-P5K, MEKK1, and DAG kinase.
The Rho family GTPases Rac1, RhoA, and Cdc42 as well as the
Ras family of GTPases translocate to the plasma membrane upon
activation (Collins, 2003), where their regulation by tetraspanins
continues to be defined.
For example, CD151 was demonstrated to regulate Cdc42
for the control of cellular adhesion. Using A431 cells, CD151
antibody treatment or CD151 overexpression was found
to increase Cdc42 activation, which the authors suggest
controls actin reorganization, promoting filopodia-based
adhesions (Shigeta et al., 2003). Another study assessed how the
coexpression of CD9 and TGF-α regulates GTPase signaling,
finding increased and decreased levels of activated Rac1 and
RhoA respectively, with Cdc42 levels remaining unchanged
upon coexpression of CD9 and TGF-α (Imhof et al., 2008).
This shift in signaling was determined to be due to enhanced
EGFR signaling, which ultimately contributed to enhanced
stress fiber formation. Additionally, the overexpression of CD82
was shown to decrease the proportion of GTP-bound Rac1,
while RhoA and Cdc42 levels remained unchanged (Liu et al.,
2012).
Previous work also demonstrated that CD151 promotes
the association between CD151-β1 complexes and Ras, Rac1
or Cdc42. Immunofluorescence imaging showed that CD151
regulates the translocation of Rac1 and Ras to the membrane
and promoted colocalization with β1 integrins (Hong et al.,
2012). Interestingly, through the use of a CD151 chimera with
disrupted α3β1 integrin association, the authors showed that this
mutant is unable to recruit Rac1 to the membrane. Therefore,
integrins also have the capacity to link GTPases to tetraspanins
in a manner similar to what was previously proposed for PKC
and tetraspanins (Zhang et al., 2001; Li Q. et al., 2013). An
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association between Rac1 and the C-terminal, cytoplasmic region
of CD81 has also been suggested based on the use of an eight
amino acid C-terminal tail peptide (Tejera et al., 2013). Future
experiments that mutate or delete the CD81 C-terminal tail will
be important to demonstrate that such a mutation eliminates
Rac1 association, further validating the interaction. Furthermore,
upon EGF stimulation, it was shown that knockdown of CD81
increases Rac activation. A more recent study identified a
correlation between CD9 expression and GTP bound Rac1
expression in acute lymphoblastic leukemia patient samples
(Arnaud et al., 2015). Moreover, this group also determined that
the C-terminal tail of CD9 is important for regulating Rac1
activation. Interestingly, the C-terminal region of CD9 has two
known palmitoylation sites (Charrin et al., 2002), and Rac can
also be palmitoylated (Tsai and Philips, 2012). Therefore, it is
possible that these post-translational modifications may help
to anchor tetraspanins and GTPases into similar membrane
compartments.
Tetraspanin regulation of RhoA signaling, which can promote
changes in cytoskeletal organization, has also been characterized
(Sit and Manser, 2011). Using human aortic smooth muscle
cells, CD9 knockdown decreased the expression of GTP-bound
RhoA, leading to defects in cellular morphology, spreading and
contraction (Herr et al., 2014). The authors suggest that integrins
are involved in CD9-mediated alterations in RhoA activation
by possibly stabilizing integrin-ECM interactions, augmenting
RhoA activation. Interestingly, a recent report demonstrates
that the loss of CD151 in breast cancer cells resulted in
increased RhoA activation as quantified using FRET biosensors
(Novitskaya et al., 2014). These data are contrary to Hong et al.
(2012), who showed no change in Rho activation upon CD151
depletion. However, the change in FRET efficiency detected
was <5%, which would likely be below the detection of the
small GTPase protein pull-down assays used by Hong et al.
Moreover, a separate report demonstrated that the knockdown
of CD151 in human dermal microvascular endothelial cells
resulted in an increase in RhoA-GTP and decreased Rac1-GTP
(Zhang et al., 2011). Future studies focused on the mechanism
by which tetraspanins can modulate GTPase activation will be
important for determining how certain tetraspanins may be
targeted to control specific GTPase activities in specialized cell
types.
β-Catenin
β-catenin is a component of the Wnt signaling pathway that
binds to the cytosolic portion of cadherins to initiate cellular
signaling (Valenta et al., 2012). Through this complex formation,
β-catenin promotes the internalization and recycling of E-
cadherin, thereby destabilizing the complex and ultimately
reducing cell-cell adhesion. Researchers determined that
ectopic CD82 expression in h1299 cells relocalizes β-catenin
to E-cadherin at the cell membrane, which stabilizes complex
formation (Abe et al., 2008). Furthermore, they showed that
ectopic CD82 expression increased cancer cell aggregation.
To assess the downstream consequences of altered β-catenin
localization, the authors stimulated cells with EGF or hepatocyte
growth factor (HGF), demonstrating that ectopic expression
of CD82 diminished β-catenin phosphorylation. While β-
catenin phosphorylation is known to destabilize the E-cadherin
complex, the mechanism for tetraspanin involvement remains
to be clearly defined. Based on our previous work with
N-cadherin (Marjon et al., 2016), we speculate that the
CD82 scaffold might contribute to cadherin clustering,
which may stabilize β-catenin membrane interactions,
thereby protecting β-catenin from phosphorylation and
down-regulation.
More recently, CD63 was shown to stabilize β-catenin
signaling. In this study, shRNA knockdown of CD63 decreased
β-catenin protein expression levels, which was suggested to
occur through diminished levels of inactive GSK3β, leading
to increased levels of phosphorylated β-catenin (Seubert et al.,
2015). Furthermore, decreased levels of the β-catenin targets,
MMP-2 and PAI-1, were detected, demonstrating CD63-
mediated changes in downstream β-catenin signaling. The
authors went on to find that the reduced expression of CD63
diminishes the metastatic potential of lung cancer cells, while
the overexpression promoted tumor aggressiveness. However,
modulations in signaling induced by CD63 overexpression
were not explored. A previous study provided evidence that
disrupting the interaction between the α3β1 integrin and
CD151 enhanced β-catenin phosphorylation (Chattopadhyay
et al., 2003). Therefore, it is plausible that the combination of
integrins and tetraspanins serves to stabilize β-catenin within
TEMs.
TETRASPANIN POST-TRANSLATIONAL
MODIFICATIONS AND SIGNALING
Palmitoylation
S-palmitoylation is the addition of a 16-carbon fatty acid chain,
palmitate, to cysteine residues of either cytoplasmic ormembrane
proteins (Blaskovic et al., 2013). Palmitoylation of cytoplasmic
proteins promotes membrane anchoring, while palmitoylation
of membrane proteins facilitates trafficking and membrane
organization. Palmitoylation has been confirmed for tetraspanins
CD9, CD151 (Yang et al., 2002), CD81 (Delandre et al., 2009),
and CD82 (Mazurov et al., 2007), however other tetraspanins
also contain conserved cysteine residues that are predicted to
be palmitoylated. The defined role for palmitoylation is to
modulate TEM formation (Yang et al., 2004). Therefore, we
took a closer examination of how tetraspanin palmitoylation
contributes to the signaling that occurs downstream of TEM
associated proteins.
For example, the expression of the palmitoylation
deficient form of CD151 weakened its association with
integrins (Berditchevski et al., 2002), resulting in diminished
phosphorylation of AKT in response laminin-5 engagement.
These data indicate that palmitoylation-mediated disruption of
TEMs can reduce downstream signaling responses. Additionally,
a palmitoylation deficient form of Tetraspanin12 was shown
to have diminished association with ADAM10, resulting in
decreased ADAM10 activity as assessed by APP shedding
(Xu et al., 2009). Recent work from our lab has shown
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that overexpression of a palmitoylation-deficient form of
CD82 diminishes PKC membrane stabilization, reducing
ERK1/2 activation, and downstream leukemia colony
formation (Termini et al., 2016). Collectively, these studies
demonstrate that tetraspanin palmitoylation contributes
significantly to the regulation of downstream cellular signaling.
Intracellular signaling molecules such as Ras (Eisenberg
et al., 2013), Rac (Tsai and Philips, 2012), and PKC (Ford
et al., 1998) can themselves be palmitoylated to assist with
their membrane anchorage. As tetraspanin palmitoylation
is thought to regulate lateral protein associations within
TEMs, perhaps tetraspanin palmitoylation functions in
concert with the palmitoylation of cytoplasmic proteins to
produce stable membrane interactions critical for sustained
signaling.
Glycosylation
Although the large extracellular loop of many tetraspanins
has been demonstrated to have one or more potential N-
linked glycosylation sites, little is known about the functional
consequences of this post-translational modification. The N-
glycosylation pattern of CD82 was recently identified using
proteomics and glycomics, determining that there are three
putative N-glycosylation sites (Wang H. et al., 2012). Previously,
these sites were suggested to regulate apoptosis, however
the researchers did not examine the signaling that led to
these apoptotic changes (Ono et al., 1999). Interestingly, the
photoreceptor-specific tetraspanin retinal degeneration slow
(RDS) can also be glycosylated (Kedzierski et al., 1999; Conley
et al., 2012). More recently, the function of RDS glycosylation
was re-examined by expressing a glycosylation deficient version
of RDS in mice, which identified differential functional outcomes
in cones vs. rod photoreceptor cells (Stuck et al., 2015).
Moreover, the authors determined that glycosylation regulates
the formation of RDS complexes with another tetraspanin ROM-
1, demonstrating that glycosylation can modulate tetraspanin
complex formation. A recent report from our laboratory
examined the role of CD82 glycosylation with respect to acute
myeloid leukemia homing (Marjon et al., 2016). In this study,
we demonstrated that mutation of the three glycosylation sites
within CD82 to inhibit glycosylation resulted in increased AML
cell homing to the bone marrow, which we linked to increased
molecular packing of N-cadherin via super resolution imaging.
Although we have yet to examine signaling deficits in cells with
disrupted CD82 glycoslation, it is possible that these changes
in the molecular organization of N-cadherin may modulate the
activation or stability of p120 catenin or β-catenin signaling
downstream of N-cadherin.
Ubiquitination
Protein ubiquitination is important for regulating cellular
signaling by selectively targeting proteins for degradation.
Both CD81 and CD151 were shown to interact with gene
related to anergy in lymphocytes (GRAIL), which promotes
tetraspanin ubiquitination, ultimately downregulating surface
tetraspanin expression (Lineberry et al., 2008). Interestingly, it
was determined that these tetraspanins can only be ubiquitinated
at their N-terminus. Through mutational studies, it was shown
that mutation of K8 and K11 diminished the ubiquitination
of CD81, while mutation of K8, K11, and K17 ablated the
ubiquitination of CD151. More recently it was demonstrated
that TSPAN6 interacts with the adaptor mitochondrial antiviral
signaling (MAVs) in 293T cells to inhibit RIG-I-like receptor
(RLR) mediated signaling (Wang Y. et al., 2012). The authors
went on to show that induction of RLR signaling promoted the
ubiquitination of TSPAN6 at K11, K16, and K43, which are sites
found within the TM1 of TSPAN6. Additionally, the authors
determined that TSPAN6 ubiquitination serves to inhibit the
formation of the signalosome, effectively down-regulating RLR
signaling. As ubiquitination can target proteins for degradation,
we suspect that tetraspanin ubiquitination will be a regulatory
mechanism to allow for specific and efficient attenuation of
tetraspanin-mediated signaling.
CONCLUDING REMARKS
Tetraspanins and their formation into TEMs enable the
compartmentalization of membrane receptors within the plasma
membrane. In this review, we focus on how tetraspanins also
serve to connect these membrane-associated molecules with
intracellular signaling complexes. It is now clear that tetraspanins
regulate diverse cell signaling pathways that impact a breadth
of biological processes. However, though numerous signaling
molecules have been demonstrated to associate with tetraspanins,
the mechanisms by which tetraspanins precisely modulate
signal transduction remains relatively undefined. Future studies
focused on how domains andmotifs within tetraspanins promote
or perhaps attenuate cellular signaling will help us understand
the specific mechanisms used by this family of proteins to control
signaling. Many laboratories are now using sophisticated imaging
techniques to provide novel insight into the spatiotemporal
interactions mediated by tetraspanins and TEMs. These studies
will help to define how the scaffolding properties of tetraspanins
contribute to the formation, stabilization and dynamics of signal
transduction complexes at the plasma membrane. Moreover,
these studies may provide the needed insight to establish
tetraspanins and TEMs as potential therapeutic targets for
the modulation of aberrant signal transduction that mediates
processes such as inflammation, wound healing, and various
types of cancer.
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